Title:
Biography: Caifu has more than 25 years of biotech R&D and academic research experiences in qPCR and NGS new product or application development. He has been CTO at 3D Medicines since December 2018. Prior to 3D Medicines, he was SVP of Genomics R&D at IDT/Danaher on 2014-2018, VP of Genomics R&D at Applied Biosystems/Thermo Fisher on 1998-2014 and VP of Molecular Biology R&D at Pall on 2010-2012. He has developed >90 RUO/LDT/CDx products in qPCR and NGS and established broad & productive scientific collaborations in precision cancer care, microRNAs, stem cells and single cell analysis. Before joining Applied Biosystems, he received his postdoctoral training at Harvard Medical School and Ph.D. in Genetics at University of Missouri-Columbia. Caifu is the author of 56 peer-reviewed papers, 8 book chapters, holder of 37 patents or patent publications, invited speakers for scientific conferences, reviewer for peer-reviewed scientific journals, and winners of numerous awards.